High Tower Advisors, LLC Biomarin Pharmaceutical Inc Transaction History

High Tower Advisors, LLC

  • $84.5 Billion
  • Q3 2025

A detailed history of High Tower Advisors, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 42,530 shares of BMRN stock, worth $2.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,530
Previous 39,894 6.61%
Holding current value
$2.33 Million
Previous $2.19 Million 5.06%
% of portfolio
0.0%
Previous 0.0%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025
BUY
$52.62 - $61.93 $138,706 - $163,247
2,636 Added 6.61%
42,530 $2.3 Million
Q2 2025

Aug 11, 2025
SELL
$54.08 - $68.32 $317,774 - $401,448
-5,876 Reduced 12.84%
39,894 $2.19 Million
Q1 2025

May 12, 2025
BUY
$61.25 - $72.83 $263,497 - $313,314
4,302 Added 10.37%
45,770 $3.24 Million
Q4 2024

Feb 07, 2025
BUY
$61.93 - $70.49 $676,894 - $770,455
10,930 Added 35.79%
41,468 $2.73 Million
Q3 2024

Nov 14, 2024
BUY
$69.02 - $93.84 $1.92 Million - $2.61 Million
27,843 Added 1033.14%
30,538 $2.15 Million
Q2 2024

Aug 13, 2024
SELL
$74.43 - $92.22 $331,511 - $410,747
-4,454 Reduced 62.3%
2,695 $221,000
Q1 2024

May 06, 2024
SELL
$83.81 - $99.0 $93,112 - $109,989
-1,111 Reduced 13.45%
7,149 $624,000
Q4 2023

Feb 12, 2024
BUY
$76.22 - $98.51 $42,911 - $55,461
563 Added 7.31%
8,260 $796,000
Q3 2023

Nov 08, 2023
BUY
$85.07 - $94.48 $236,154 - $262,276
2,776 Added 56.41%
7,697 $681,000
Q2 2023

Aug 14, 2023
BUY
$86.68 - $100.3 $2,167 - $2,507
25 Added 0.51%
4,921 $426,000
Q1 2023

May 11, 2023
SELL
$87.74 - $117.27 $19,039 - $25,447
-217 Reduced 4.24%
4,896 $476,000
Q4 2022

Feb 08, 2023
BUY
$80.93 - $108.63 $25,492 - $34,218
315 Added 6.57%
5,113 $529,000
Q3 2022

Nov 09, 2022
SELL
$82.16 - $96.94 $418,276 - $493,521
-5,091 Reduced 51.48%
4,798 $406,000
Q2 2022

Aug 10, 2022
SELL
$71.48 - $86.85 $41,172 - $50,025
-576 Reduced 5.5%
9,889 $817,000
Q1 2022

May 12, 2022
SELL
$74.28 - $92.69 $768,500 - $958,970
-10,346 Reduced 49.71%
10,465 $808,000
Q4 2021

Feb 10, 2022
BUY
$71.72 - $91.47 $456,210 - $581,840
6,361 Added 44.02%
20,811 $1.84 Million
Q3 2021

Nov 12, 2021
BUY
$74.77 - $85.47 $743,139 - $849,486
9,939 Added 220.33%
14,450 $1.12 Million
Q2 2021

Aug 06, 2021
BUY
$75.51 - $84.79 $24,087 - $27,048
319 Added 7.61%
4,511 $378,000
Q1 2021

May 10, 2021
BUY
$74.73 - $90.69 $13,376 - $16,233
179 Added 4.46%
4,192 $319,000
Q4 2020

Feb 10, 2021
BUY
$72.61 - $90.2 $291,383 - $361,972
4,013 New
4,013 $353,000
Q3 2020

Nov 13, 2020
SELL
$71.87 - $131.03 $166,019 - $302,679
-2,310 Closed
0 $0
Q2 2020

Aug 10, 2020
SELL
$79.55 - $124.22 $7,000 - $10,931
-88 Reduced 3.67%
2,310 $281,000
Q1 2020

May 21, 2020
SELL
$71.37 - $96.85 $6,494 - $8,813
-91 Reduced 3.66%
2,398 $201,000
Q4 2019

Feb 14, 2020
BUY
$64.27 - $86.37 $159,968 - $214,974
2,489 New
2,489 $208,000
Q3 2019

Nov 12, 2019
SELL
$67.4 - $85.11 $340,437 - $429,890
-5,051 Closed
0 $0
Q2 2019

Aug 13, 2019
SELL
$80.35 - $93.9 $77,939 - $91,083
-970 Reduced 16.11%
5,051 $438,000
Q1 2019

May 15, 2019
SELL
$84.2 - $98.62 $11,198 - $13,116
-133 Reduced 2.16%
6,021 $535,000
Q4 2018

Feb 14, 2019
BUY
$80.14 - $106.07 $84,707 - $112,115
1,057 Added 20.74%
6,154 $530,000
Q3 2018

Nov 09, 2018
BUY
$93.92 - $105.72 $3,381 - $3,805
36 Added 0.71%
5,097 $493,000
Q2 2018

Aug 14, 2018
BUY
$76.01 - $99.03 $136,894 - $178,353
1,801 Added 55.25%
5,061 $479,000
Q1 2018

May 15, 2018
SELL
$77.67 - $92.63 $41,398 - $49,371
-533 Reduced 14.05%
3,260 $264,000
Q4 2017

Feb 14, 2018
BUY
$80.76 - $95.13 $97,396 - $114,726
1,206 Added 46.62%
3,793 $339,000
Q3 2017

Nov 14, 2017
SELL
$80.6 - $94.95 $40,783 - $48,044
-506 Reduced 16.36%
2,587 $244,000
Q2 2017

Aug 14, 2017
BUY
N/A
3,093
3,093 $282,000

Others Institutions Holding BMRN

# of Institutions
669
Shares Held
182M
Call Options Held
1.52M
Put Options Held
1.01M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $10.2B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email